체외 독성 시험 : 기술 및 세계 시장

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

The Asia-Pacific market for in vitro toxicity testing was valued at $3.4 billion in 2025 and is estimated to reach $6 billion by 2030, at a CAGR of 11.9% from 2025 to 2030.

The North American market for in vitro toxicity testing was valued at $5.9 billion in 2025 and is estimated to reach $9.7 billion by 2030, at a CAGR of 10.2% from 2025 to 2030.

Report Scope

This report offers a comprehensive analysis of the global in vitro toxicity testing market, including current market dynamics, emerging trends, and future growth prospects. The analysis is based on market data from 2024 as the base year, with estimates for 2025 and compound annual growth rate projections for the period from 2025 through 2030. The report evaluates both global and regional markets, providing insights into how regulatory evolution, technological innovation, and shifting industry practices are influencing demand for in vitro toxicity testing solutions.

The market is segmented by toxicity endpoint and test, including absorption, distribution, metabolism, and excretion (ADME) testing, genotoxicity testing, dermal toxicity, cytotoxicity, ocular toxicity, skin irritation, corrosion and sensitization, organ toxicity, phototoxicity testing, carcinogenicity, developmental and reproductive toxicity (DART), neurotoxicity, and other toxicity endpoints. By tool and technology, the market is segmented into cell culture technologies, high-throughput screening (HTS), multi-omics, and other emerging technologies, such as advanced in vitro models and integrated new approach methodologies.

By component, the report segments the market into equipment, reagents and kits, software and analytics, and services. By assay type, the market is segmented into cellular toxicity assays, biochemical toxicity assays, in silico assays, and other assay types, including advanced and hybrid approaches. By end-use segment, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), cosmetics and personal care companies, and other end users, including chemicals, medical devices, agrochemicals, and academic or government research institutions. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.

Report Includes

• 175 data tables and 50 additional tables
• An overview of the global market for in vitro toxicity testing
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to in vitro toxicity testing, accompanied by a market share analysis by toxicity endpoints, assay types, technology platforms, components, end-users, and region
• Analysis of current and future demand in the global in vitro toxicity testing, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges, and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key market participants in in vitro toxicity testing, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Eurofins Scientific, Charles River Laboratories, and SGS General Surveillance Co. SA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factor Analysis
• Impact of U.S. Tariffs on the Pharmaceutical Industry
• Rising Pharmaceutical R&D Costs and Return on Investment Pressures
• Impact of the Ukraine-Russia War on the In Vitro Toxicity Testing Industry
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Regulatory and Legislative Shift Toward Non-Animal Testing
• Cost Efficiency and Early Attrition Reduction in Drug Development
• Technological Maturation of Human-Relevant In Vitro Platforms and Data-Driven Toxicology
• Market Restraints
• Validation, Standardization, and Regulatory Acceptance Gaps
• High Capital Intensity and Infrastructure Requirements
• Limited Ability of In Vitro Systems to Capture Whole-System and Long-Term Toxicity
• Market Opportunities
• Regulatory Enablement and Validation Services
• Personalized and Precision Toxicology Using Patient-Derived In Vitro Models

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies

• Overview
• Federal In Vitro Screening Programs and the Scale of Data Generation
• Advanced Cell Systems: 3D Cultures and Human-Relevant Models
• Microphysiological Systems and Organ-on-a-Chip Platforms
• Mechanistic Biomarkers and Multi-Omics Evidence
• Patent Analysis
• Patents, by Year
• Patents, by Jurisdiction
• Patents, by Leading Inventor
• Key Takeaways

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Global Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test
• Key Takeaways
• ADME Testing
• Genotoxicity Testing
• Dermal Toxicity
• Cytotoxicity
• Ocular Toxicity
• Skin Irritation, Corrosion, and Sensitization
• Organ Toxicity
• Phototoxicity Testing
• Carcinogenicity
• Neurotoxicity
• DART
• Others
• Global In Vitro Toxicity Testing Market, by Tool/Technology
• Key Takeaways
• Cell Culture
• High-Throughput Screening (HTS)
• Multi-Omics
• Others
• Global In Vitro Toxicity Testing Market, by Component
• Key Takeaways
• Equipment
• Reagents and Kits
• Software and Analytics
• Services
• Global In Vitro Toxicity Testing Market, by Assays
• Key Takeaways
• Cellular Toxicity Assays
• Biochemical Toxicity Assays
• In Silico Assays
• Others
• Global In Vitro Toxicity Testing Market, by End-Use Industry
• Key Takeaways
• Pharmaceutical and Biotechnology
• CROs
• Cosmetics and Personal Care
• Others
• Geographic Breakdown
• Global Market for In Vitro Toxicity Testing by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Rest of South America

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Company Share Analysis

Chapter 8 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ABCAM LTD.
• AGILENT TECHNOLOGIES INC.
• ARAGEN LIFE SCIENCES LTD.
• BIO-RAD LABORATORIES INC.
• BIOIVT
• CHARLES RIVER LABORATORIES
• EUROFINS SCIENTIFIC
• EVOTEC SE
• GENTRONIX
• LABCORP.
• MERCK KGAA
• MOLECULAR DEVICES LLC.
• PROMEGA CORP.
• SGS Societe Generale de Surveillance SA
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC
• XENOMETRIX AG
• Emerging Companies in the In Vitro Toxicity Testing Market